OrganizationsProkarium

Products 1 to 2 of 2

Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (1 year ago)
Date last modified: 2019/09/12 15:18 (1 year ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Vaxonella by Prokarium
Biotech components: Bacteria
Business models: B2C
Country of production: UK
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2019/05/15 16:12 (2 years ago)
Known funding amount: 12,600,000 USD
Funding types: Venture Capital
Industry: Health
Market status: On the market + Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product